Reading basis: Based on the publisher-hosted abstract. The full manuscript and supplements were not reviewed for this note. The condition studied is ventricular septal defect (VSD).

The condition and comparison

The study concerned perimembranous VSD. Investigators randomized 108 participants to a fully bioabsorbable or nitinol occluder and followed them for 24 months. It was designed as a noninferiority comparison. [1]

The study at a glanceDesign and follow-up—not an individual outcome prediction.
  1. Who108 participants with VSD
  2. ComparisonBioabsorbable vs nitinol device
  3. Design / endpointNoninferiority comparison
  4. ObservationFollow-up to 24 months

Original explanatory diagram based on source 1. This study concerns a different condition from PFO.

What the abstract describes

The authors reported successful implantation in all enrolled participants and no residual shunt above 2 mm during follow-up. They also reported fewer sustained conduction blocks in the bioabsorbable group at 24 months. These findings refer to this VSD trial, not PFO closure. [1]

What this note cannot establish

An abstract cannot provide the same detail as the full protocol, eligibility criteria and supplementary results. Our interpretation is deliberately narrow: this is related research into a different application of bioabsorbable technology. It does not establish that a specific PFO device is suitable, safer or available for an individual patient.

A practical way to compare papers

Start a short reading list for your appointment. Next to each paper, record the condition studied, the exact device and the question you want to ask. Keep related background studies separate from direct evidence for your proposed treatment.

  • Which paper directly studies the procedure being discussed with me?
  • What information is missing from the abstract?
  • Which study details should my clinician help me interpret?

Where to read the original

  1. Transcatheter closure of perimembranous ventricular septal defect using a novel fully bioabsorbable occluder: multicenter randomized controlled trial. Science Bulletin. 2023. DOI: 10.1016/j.scib.2023.04.027.

    Original publication ↗ · Read publisher-hosted abstract ↗

This original reading note is prepared for the China Hospital Access website. It is not authored or endorsed by the researchers, and is not a reproduction of their publication. It provides general information, not an individual medical assessment.

Continue reading

Biodegradable PFO Closure: Reading the Circulation Trial ↗Bioresorbable PFO Closure: What Still Needs to Be Answered? ↗The JAMA Bioresorbable Occluder Trial: Why ASD Is Not PFO ↗
Questions to discuss with your clinical team ↗